Related Experiment Videos
Carcinoembryonic antigen in bronchogenic carcinoma
Neoplasma
|January 1, 1987
Summary
Carcinoembryonic antigen (CEA) levels can help diagnose bronchogenic carcinoma, differentiating it from noncancerous lung diseases. However, CEA levels did not significantly differ among various morphological types of lung cancer.
Area of Science:
- Oncology
- Pulmonology
- Clinical Chemistry
Background:
- Carcinoembryonic antigen (CEA) is a tumor marker.
- Accurate diagnosis of bronchogenic carcinoma is crucial for effective treatment.
Purpose of the Study:
- To evaluate the diagnostic utility of serum CEA levels for bronchogenic carcinoma.
- To assess the correlation between CEA levels and morphological subtypes of lung cancer.
Main Methods:
- Serum samples were collected from patients with bronchogenic carcinoma, noncancerous lung diseases, and healthy individuals.
- CEA concentrations were measured in all serum samples.
- Statistical analysis was performed to compare CEA levels across groups and subtypes.
Main Results:
- Elevated serum CEA levels were observed in 32% of patients with bronchogenic carcinoma.
- No statistically significant differences in CEA levels were found among different morphological types of bronchogenic carcinoma.
- Statistically significant differences were observed between bronchogenic carcinoma patients and both noncancerous lung disease and healthy control groups.
Conclusions:
- Serum CEA measurement is a valuable tool for distinguishing bronchogenic carcinoma from noncancerous lung conditions.
- CEA levels are not effective in differentiating between morphological subtypes of lung cancer.